Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Mobile Teledermatology for Melanoma Detection. Response letter.

Naldi L, Cazzaniga S.

J Am Acad Dermatol. 2019 Jul 3. pii: S0190-9622(19)32289-3. doi: 10.1016/j.jaad.2019.06.1290. [Epub ahead of print] No abstract available.

PMID:
31279033
2.

Mepolizumab failed to affect bullous pemphigoid: a randomized, placebo-controlled, double-blind phase 2 pilot study.

Simon D, Yousefi S, Cazzaniga S, Bürgler C, Radonjic S, Houriet C, Heidemeyer K, Klötgen HW, Kozlowski E, Borradori L, Simon HU.

Allergy. 2019 Jun 22. doi: 10.1111/all.13950. [Epub ahead of print] No abstract available.

PMID:
31230371
3.

Monomeric light harvesting complexes enhance excitation energy transfer from LHCII to PSII and control their lateral spacing in thylakoids.

Dall'Osto L, Cazzaniga S, Zappone D, Bassi R.

Biochim Biophys Acta Bioenerg. 2019 Jun 19. pii: S0005-2728(19)30059-3. doi: 10.1016/j.bbabio.2019.06.007. [Epub ahead of print]

PMID:
31226317
4.

A Retrospective Cohort Study on Patients with Lentigo Maligna Melanoma.

Fröhlich SM, Cazzaniga S, Kaufmann LS, Hunger RE, Seyed Jafari SM.

Dermatology. 2019;235(4):340-345. doi: 10.1159/000499689. Epub 2019 May 21.

PMID:
31112945
5.

In vitro and in vivo investigation of chlorophyll binding sites involved in non-photochemical quenching in Chlamydomonas reinhardtii.

Perozeni F, Cazzaniga S, Ballottari M.

Plant Cell Environ. 2019 Aug;42(8):2522-2535. doi: 10.1111/pce.13566. Epub 2019 May 9.

PMID:
30997927
6.

Emergency Consultations in Dermatology in a Secondary Referral Hospital in Southern Switzerland: A Prospective Cross-Sectional Analysis.

Pelloni L, Cazzaniga S, Naldi L, Borradori L, Mainetti C.

Dermatology. 2019;235(3):243-249. doi: 10.1159/000498850. Epub 2019 Mar 28.

PMID:
30921799
7.

Mobile teledermatology for melanoma detection: Assessment of the validity in the framework of a population-based skin cancer awareness campaign in northern Italy.

Cazzaniga S, Castelli E, Di Landro A, Di Mercurio M, Imberti G, Locatelli GA, Raponi F, Vezzoli P, Gambini D, Damiani G, Zucchi A, Naldi L.

J Am Acad Dermatol. 2019 Jul;81(1):257-260. doi: 10.1016/j.jaad.2019.02.036. Epub 2019 Feb 21. No abstract available.

PMID:
30797846
8.

LHCSR3 is a nonphotochemical quencher of both photosystems in Chlamydomonas reinhardtii.

Girolomoni L, Cazzaniga S, Pinnola A, Perozeni F, Ballottari M, Bassi R.

Proc Natl Acad Sci U S A. 2019 Feb 19. pii: 201809812. doi: 10.1073/pnas.1809812116. [Epub ahead of print]

PMID:
30782831
9.

Psoriasis Incidence and Lifetime Prevalence: Suggestion for a Higher Mortality Rate in Older Age-classes among Psoriatic Patients Compared to the General Population in Italy.

Pezzolo E, Cazzaniga S, Colombo P, Chatenoud L, Naldi L.

Acta Derm Venereol. 2019 Apr 1;99(4):400-403. doi: 10.2340/00015555-3130.

10.

Atopic dermatitis in young adult italian males: persistent and adult-onset varieties did not differ clinically and as for allergological variables.

Ingordo V, Cazzaniga S, Naldi L, Perrucci S, Barbierato M, Crociata F, Cusano F.

G Ital Dermatol Venereol. 2019 Jan 16. doi: 10.23736/S0392-0488.18.06239-9. [Epub ahead of print]

PMID:
30650956
11.

Use of fumaric acid derivatives (FADs) in Italian reference centres for psoriasis.

Damiani G, Cazzaniga S, Naldi L; PsoReal Study Group.

G Ital Dermatol Venereol. 2019 Jan 9. doi: 10.23736/S0392-0488.18.06032-7. [Epub ahead of print]

PMID:
30636394
12.

Pushing and loss of elastic fibers are highly specific for melanoma and rare in melanocytic nevi.

Stillhard A, Cazzaniga S, Borradori L, Beltraminelli H.

Arch Dermatol Res. 2019 Mar;311(2):99-107. doi: 10.1007/s00403-018-1885-x. Epub 2018 Dec 13.

PMID:
30547366
13.

'High dose' vs. 'medium dose' UVA1 phototherapy in italian patients with severe atopic dermatitis.

Pacifico A, Iacovelli P, Damiani G, Ferraro C, Cazzaniga S, Conic RRZ, Leone G, Morrone A.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):718-724. doi: 10.1111/jdv.15362. Epub 2018 Dec 28.

PMID:
30468530
14.

Socioeconomic Status and the Prevalence of Skin and Atopic Diseases in Five European Countries.

Ofenloch RF, Schuttelaar ML, Svensson Å, Bruze M, Naldi L, Cazzaniga S, Elsner P, Gonçalo M, Diepgen TL.

Acta Derm Venereol. 2019 Mar 1;99(3):309-314. doi: 10.2340/00015555-3082.

15.

Correlation of Vascular Endothelial Growth Factor subtypes and their receptors with melanoma progression: A next-generation Tissue Microarray (ngTMA) automated analysis.

Seyed Jafari SM, Wiedmer C, Cazzaniga S, Frangež Ž, Shafighi M, Beltraminelli H, Weber B, Simon HU, Hunger RE.

PLoS One. 2018 Nov 8;13(11):e0207019. doi: 10.1371/journal.pone.0207019. eCollection 2018.

16.

Correction to: "Familial venoms": a thallium intoxication cluster.

Ratti F, Facchini A, Beck E, Cazzaniga S, Francesconi S, Tedesco C, Terrani A, Ciceri G, Colombo R, Saini M, Petrolini VM, Citerio G.

Intensive Care Med. 2018 Dec;44(12):2321-2322. doi: 10.1007/s00134-018-5418-z.

PMID:
30374694
17.

"Familial venoms": a thallium intoxication cluster.

Ratti F, Facchini A, Beck E, Cazzaniga S, Francesconi S, Tedesco C, Terrani A, Ciceri G, Colombo R, Saini M, Petrolini VM, Citerio G.

Intensive Care Med. 2018 Dec;44(12):2298-2299. doi: 10.1007/s00134-018-5403-6. Epub 2018 Oct 6. No abstract available. Erratum in: Intensive Care Med. 2018 Oct 29;:.

PMID:
30293149
18.

An original exploration of genital lichen sclerosus: the semantic connectivity map.

Cazzaniga S, Naldi L, Virgili A, Di Landro A, Simon D, Corazza M, Borghi A; other members of the GLS Italian Study Group.

J Eur Acad Dermatol Venereol. 2019 Feb;33(2):e59-e62. doi: 10.1111/jdv.15191. Epub 2018 Aug 14. No abstract available.

PMID:
30051519
19.

Reply to: "Bullous pemphigoid and diabetes mellitus: Are we missing the larger picture?"

Benzaquen M, Borradori L, Cazzaniga S, Berbis P, Feldmeyer L.

J Am Acad Dermatol. 2018 Aug;79(2):e29-e30. doi: 10.1016/j.jaad.2018.03.049. No abstract available.

PMID:
30012286
20.

Factors influencing sessions' and speakers' evaluation: an analysis of seven consecutive European Academy of Dermatology and Venereology congress editions.

Cazzaniga S, Scerri L, Gabbud JP, Arenberger P, Borradori L, Naldi L.

J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2307-2313. doi: 10.1111/jdv.15178. Epub 2018 Aug 5.

PMID:
29992638
21.

Chronic hand eczema: A prospective analysis of the Swiss CARPE registry focusing on factors associated with clinical and quality of life improvement.

Cazzaniga S, Ballmer-Weber BK, Gräni N, Spring P, Bircher A, Anliker M, Sonntag AK, Piletta P, Huber C, Diepgen TL, Apfelbacher C, Naldi L, Borradori L, Simon D.

Contact Dermatitis. 2018 Sep;79(3):136-148. doi: 10.1111/cod.13041. Epub 2018 Jun 25.

PMID:
29943397
22.

A Retrospective Cohort Study on Patients with Hidradenitis Suppurativa.

Seyed Jafari SM, Knüsel E, Cazzaniga S, Hunger RE.

Dermatology. 2018;234(1-2):71-78. doi: 10.1159/000488344. Epub 2018 May 14.

PMID:
29758553
23.

Survey of cutaneous adverse reactions to targeted cancer therapies: value of dermatological advice.

Damiani G, Manganoni A, Cazzaniga S, Naldi L; OncoSkin working group.

G Ital Dermatol Venereol. 2018 May 11. doi: 10.23736/S0392-0488.18.06033-9. [Epub ahead of print]

PMID:
29756421
24.

Acne at the Regional Dermatology Training Centre (RDTC), Tanzania: clinical, social and demographic characteristics of patients with focus on severity factors.

Amani Uwajeni A, Mshana J, Kiprono S, Mavura D, Masenga EJ, Cazzaniga S, Todd G, Beltraminelli H.

J Eur Acad Dermatol Venereol. 2018 Dec;32(12):e451-e453. doi: 10.1111/jdv.15041. Epub 2018 Jul 17. No abstract available.

PMID:
29729198
25.

Validation of a visual-aided questionnaire for the self-assessment of hidradenitits suppurativa.

Cazzaniga S, Naldi L, Damiani G, Atzori L, Patta F, Guidarelli G, Bettoli V.

J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1993-1998. doi: 10.1111/jdv.15050. Epub 2018 May 28.

PMID:
29729101
26.

Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland.

Garcia-Doval I, Descalzo MA, Mason KJ, Cohen AD, Ormerod AD, Gómez-García FJ, Cazzaniga S, Feldhamer I, Ali H, Herrera-Acosta E, Griffiths CEM, Stern RS, Naldi L; Psonet Network.

Br J Dermatol. 2018 Oct;179(4):863-871. doi: 10.1111/bjd.16715. Epub 2018 Jul 24.

PMID:
29723914
27.

Molecular basis of autotrophic vs mixotrophic growth in Chlorella sorokiniana.

Cecchin M, Benfatto S, Griggio F, Mori A, Cazzaniga S, Vitulo N, Delledonne M, Ballottari M.

Sci Rep. 2018 Apr 24;8(1):6465. doi: 10.1038/s41598-018-24979-8.

28.

Photodynamic therapy as an alternative treatment for mycosis fungoides: a systemic review and meta-analysis.

Seyed Jafari SM, Cazzaniga S, Hunger RE.

G Ital Dermatol Venereol. 2018 Dec;153(6):827-832. doi: 10.23736/S0392-0488.18.05977-1. Epub 2018 Apr 19.

PMID:
29683282
29.

Prevalence of contact allergy to metals in the European general population with a focus on nickel and piercings: The EDEN Fragrance Study.

Schuttelaar MLA, Ofenloch RF, Bruze M, Cazzaniga S, Elsner P, Gonçalo M, Naldi L, Svensson Å, Diepgen TL.

Contact Dermatitis. 2018 Jul;79(1):1-9. doi: 10.1111/cod.12983. Epub 2018 Apr 10.

30.

Association of Hidradenitis Suppurativa With T Helper 1/T Helper 17 Phenotypes: A Semantic Map Analysis.

Thomi R, Cazzaniga S, Seyed Jafari SM, Schlapbach C, Hunger RE.

JAMA Dermatol. 2018 May 1;154(5):592-595. doi: 10.1001/jamadermatol.2018.0141.

31.

Comparison of CRUSADE and ACUITY-HORIZONS Bleeding Risk Scores in Patients With Acute Coronary Syndromes.

Castini D, Centola M, Ferrante G, Cazzaniga S, Persampieri S, Lucreziotti S, Salerno-Uriarte D, Sponzilli C, Carugo S.

Heart Lung Circ. 2019 Apr;28(4):567-574. doi: 10.1016/j.hlc.2018.02.012. Epub 2018 Mar 2.

PMID:
29526417
32.

Gender differences in genital lichen sclerosus.

Virgili A, Borghi A, Cazzaniga S, DI Landro A, Naldi L, Minghetti S, Fierro MT, Verrone A, Caproni M, Micali G, Gaspari V, Papini M, DI Lernia V, Germi L, Girolomoni G, Belloni Fortina A, Cannavò SP, Bilenchi R, Corazza M; GLS Italian Study Group.

G Ital Dermatol Venereol. 2018 Jan 24. doi: 10.23736/S0392-0488.17.05819-9. [Epub ahead of print]

PMID:
29368855
33.

Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland.

Benzaquen M, Borradori L, Berbis P, Cazzaniga S, Valero R, Richard MA, Feldmeyer L.

J Am Acad Dermatol. 2018 Jun;78(6):1090-1096. doi: 10.1016/j.jaad.2017.12.038. Epub 2017 Dec 21.

PMID:
29274348
34.

Perception of ABC (asymmetry, borders, and color) parameters in the screening for melanoma: Model exercise with experienced dermatologists.

Naldi L, Falgheri G, De Bitonto A, Di Landro A, Foiadelli L, Imberti G, Riva F, Cazzaniga S.

J Am Acad Dermatol. 2018 May;78(5):996-998. doi: 10.1016/j.jaad.2017.12.035. Epub 2017 Dec 18. No abstract available.

35.

Prevalence of skin disease in a population-based sample of adults from five European countries.

Svensson A, Ofenloch RF, Bruze M, Naldi L, Cazzaniga S, Elsner P, Goncalo M, Schuttelaar MA, Diepgen TL.

Br J Dermatol. 2018 May;178(5):1111-1118. doi: 10.1111/bjd.16248. Epub 2018 Mar 30.

PMID:
29247509
36.

Functional analysis of photosynthetic pigment binding complexes in the green alga Haematococcus pluvialis reveals distribution of astaxanthin in Photosystems.

Mascia F, Girolomoni L, Alcocer MJP, Bargigia I, Perozeni F, Cazzaniga S, Cerullo G, D'Andrea C, Ballottari M.

Sci Rep. 2017 Nov 24;7(1):16319. doi: 10.1038/s41598-017-16641-6.

37.

Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center.

Vinay K, Cazzaniga S, Amber KT, Feldmeyer L, Naldi L, Borradori L.

J Am Acad Dermatol. 2018 Apr;78(4):806-808. doi: 10.1016/j.jaad.2017.11.024. Epub 2017 Nov 13. No abstract available.

38.

Real-world clopidogrel utilization in acute coronary syndromes: patients selection and outcomes in a single-center experience.

Castini D, Persampieri S, Cazzaniga S, Ferrante G, Centola M, Lucreziotti S, Salerno-Uriarte D, Sponzilli C, Carugo S.

Ther Adv Cardiovasc Dis. 2017 Dec;11(12):323-331. doi: 10.1177/1753944717738911.

39.

Evaluation of the National Skin Cancer Campaign: a Swiss experience of Euromelanoma.

Lieberherr S, Seyed Jafari SM, Cazzaniga S, Bianchi E, Schlagenhauff B, Tscharner G, Hafner J, Mainetti C, Lapointe AK, Hunger RE.

Swiss Med Wkly. 2017 Oct 19;147:w14511. doi: 10.4414/smw.2017.14511. eCollection 2017.

40.

The implementation of knowledge dissemination in the prevention of occupational skin diseases.

Wilke A, Bollmann U, Cazzaniga S, Hübner A, John SM, Karadzinska-Bislimovska J, Mijakoski D, Šimić D, Simon D, Sonsmann F, Stoleski S, Weinert P, Wulfhorst B.

J Eur Acad Dermatol Venereol. 2018 Mar;32(3):449-458. doi: 10.1111/jdv.14653. Epub 2017 Nov 22.

PMID:
29055149
41.

Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid.

Schaffer C, Buclin T, Jornayvaz FR, Cazzaniga S, Borradori L, Gilliet M, Feldmeyer L.

Dermatology. 2017;233(5):401-403. doi: 10.1159/000480498. Epub 2017 Oct 18. No abstract available.

42.

No Association between Vitiligo and Obesity: A Case-Control Study.

Dragoni F, Conti R, Cazzaniga S, Colucci R, Pisaneschi L, Naldi L, Moretti S.

Med Princ Pract. 2017;26(5):421-426. doi: 10.1159/000481436. Epub 2017 Sep 12.

43.

Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.

Busard CI, Cohen AD, Wolf P, Gkalpakiotis S, Cazzaniga S, Stern RS, Hutten BA, Feldhamer I, Quehenberger F, Lichem R, Kojanova M, Adenubiova E, Addis A, Naldi L, Spuls PI.

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):245-253. doi: 10.1111/jdv.14583. Epub 2017 Oct 17.

PMID:
28898541
44.

Postoperative complications in cirrhotic pediatric deceased donor liver transplantation: Focus on transfusion therapy.

Nacoti M, Cazzaniga S, Colombo G, Corbella D, Fazzi F, Fochi O, Gattoni C, Zambelli M, Colledan M, Bonanomi E.

Pediatr Transplant. 2017 Dec;21(8). doi: 10.1111/petr.13020. Epub 2017 Jul 5. Erratum in: Pediatr Transplant. 2018 Aug;22(5):e13225.

PMID:
28681471
45.

Patterns of chronic hand eczema: a semantic map analysis of the CARPE registry data.

Cazzaniga S, Apfelbacher C, Diepgen T, Ofenloch RF, Weisshaar E, Molin S, Bauer A, Mahler V, Elsner P, Schmitt J, Ballmer-Weber BK, Spring P, Naldi L, Borradori L, Simon D; CARPE study groups of Germany and Switzerland.

Br J Dermatol. 2018 Jan;178(1):229-237. doi: 10.1111/bjd.15660. Epub 2017 Dec 6.

PMID:
28498524
46.

Two mechanisms for dissipation of excess light in monomeric and trimeric light-harvesting complexes.

Dall'Osto L, Cazzaniga S, Bressan M, Paleček D, Židek K, Niyogi KK, Fleming GR, Zigmantas D, Bassi R.

Nat Plants. 2017 Apr 10;3:17033. doi: 10.1038/nplants.2017.33.

PMID:
28394312
47.

Risk factors for recurrence after successful treatment of warts: the role of smoking habits.

Bencini PL, Guida S, Cazzaniga S, Pellacani G, Galimberti MG, Bencini M, Naldi L.

J Eur Acad Dermatol Venereol. 2017 Apr;31(4):712-716. doi: 10.1111/jdv.14086. Epub 2017 Jan 9.

PMID:
27987326
48.

Inequalities in access to biological treatments for psoriasis: results from the Italian Psocare registry.

Naldi L, Cazzaniga S, Di Mercurio M, Grossi E, Addis A; Psocare study centres.

Br J Dermatol. 2017 May;176(5):1331-1338. doi: 10.1111/bjd.15234. Epub 2017 Apr 5.

49.

Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries.

Davila-Seijo P, Garcia-Doval I, Naldi L, Cazzaniga S, Augustin M, Rustenbach SJ, Daudén E, Dam TN, Baker C, Spuls PI, Stern RS, Cohen AD.

Acta Derm Venereol. 2017 Apr 6;97(4):516-518. doi: 10.2340/00015555-2586. No abstract available.

50.

Diagnostic value of immunohistochemistry on formalin-fixed, paraffin-embedded skin biopsy specimens for bullous pemphigoid.

Glauser S, Rutz M, Cazzaniga S, Hegyi I, Borradori L, Beltraminelli H.

Br J Dermatol. 2016 Nov;175(5):988-993. doi: 10.1111/bjd.14686. Epub 2016 Aug 30.

PMID:
27105821

Supplemental Content

Loading ...
Support Center